PHARMING (PHARM ) | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Home
Companies
PHARMING

BRIEF

published on 10/29/2024 at 14:57, 22 days 18 hours ago

Pharming Group NV: Promising Outlook Amid Executive Change

Sales Growth Executive Change Profitability Outlook Leniolisib Pharming Group
BRIEF

published on 10/29/2024 at 14:57, 22 days 18 hours ago

Pharming Group NV : Perspectives prometteuses malgré le changement de direction

Changement De Direction Croissance Des Ventes Leniolisib Groupe Pharmaceutique Perspectives De Rentabilité
PRESS RELEASE

published on 10/29/2024 at 14:52, 22 days 19 hours ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research raises price target for Pharming Group NV after Q3/24 results. CEO not seeking reappointment unrelated to business. Market undervaluing APDS drug sales potential. Expect significant revenue growth

Revenue Growth First Berlin Equity Research Pharming Group NV Q3/24 Results APDS Drug
BRIEF

published on 08/26/2024 at 16:01, 2 months 25 days ago

First Berlin Equity Research Reiterates 'Buy' Rating for Pharming Group NV

Price Target Equity Research Patient Growth Pharming Leniolisib
BRIEF

published on 08/26/2024 at 16:01, 2 months 25 days ago

First Berlin Equity Research réitère sa note « Acheter » pour Pharming Group NV

Objectif De Prix Recherche Sur Les Actions Pharmaceutique Leniolisib Croissance Des Patients
PRESS RELEASE

published on 08/26/2024 at 15:56, 2 months 25 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Pharming Group NV to Buy with a target price of €1.60. Q2/24 showed strong performance with revenue up 35% yoy and 33% qoq

Revenue First Berlin Equity Research Buy Recommendation Q2/24 Pharming Group NV
PRESS RELEASE

published on 08/09/2023 at 14:46, 1 year 3 months ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 07/18/2023 at 11:56, 1 year 4 months ago

Original-Research: Pharming (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 11/21/2024 at 09:00, 52 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 17 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 27 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 52 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 52 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 11 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 51 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 52 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 52 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 37 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 54 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 45 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 32 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE